Romidepsin targets multiple survival signaling pathways in malignant T cells

por Valdez, B C, Brammer, J E, Li, Y, Murray, D, Liu, Y, Hosing, C, Nieto, Y, Champlin, R E, Andersson, B S
Publicado 2015

P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS

por Zinzani, P. L., Zain, J., Mead, M., Casulo, C., Jacobsen, E. D., Gritti, G., Pinter-Brown, L., Isutzu, K., Cohan, D., Daugherty, M., Brammer, J. E., Mehta-Shah, N., Pro, B., Horwitz, S. M.
Publicado 2022